Changes in intravenous and oral antimicrobial prescriptions during the coronavirus disease 2019 (COVID-19) pandemic: an experience at a tertiary-care center

Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic....

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial stewardship & healthcare epidemiology : ASHE Vol. 2; no. 1; p. e53
Main Authors Murakami, Shutaro, Takamatsu, Akane, Akazawa, Manabu, Goto, Takao, Miwa, Toshiki, Terayama, Yoshiyasu, Honda, Hitoshi
Format Journal Article
LanguageEnglish
Published England Cambridge University Press 2022
Subjects
Concise Communication
Online AccessGet full text

Cover

More Information
Summary:Antimicrobial use during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary-care center was analyzed using interrupted time-series analysis. Among intravenous antimicrobials, the use of azithromycin and third-generation cephalosporins significantly decreased during the current pandemic. Similarly, the use of oral antimicrobials, including azithromycin and fluoroquinolones, also decreased.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2022.42